A., Zhao, X -J
Lear, S., Amso, Z., & Shen, W
Combined with the GLP-1-mediated improvements in insulin sensitivity and the GIP-mediated changes in lipid metabolism, the triple agonist creates conditions under which the liver clears accumulated fat at rates never before observed in clinical settings
But while many people expect some gastrointestinal discomfort on the meds, theres growing buzz about one scary side effect thats sparked several lawsuits: non-arteritic anterior ischemic optic neuropathy (NAION)
Nevertheless, daily injections can lead to a notable increase in mean GH levels, IGF-1 levels, and a minor increase in lean body mass after long-term use
If you notice any of these symptoms, stop treatment immediately and contact your provider or seek emergency care